ArticleCrohn's & colitis 3602026

Real-world outcomes of subcutaneous infliximab in a Middle Eastern inflammatory bowel disease cohort: a prospective study of switch and de novo treatment strategies.

Maryam A Alahmad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.